Experimental
US HIV Vaccine Regimen Is Safe But Futile
A US HIV vaccine research program was
rendered safe but no longer provided protection against HIV infection
according to a statement
from the US National Institute of Physical Fitness (NIH).
The trial, dubbed HPX3002/HVTN
706 or "Mosaic," began in 2019 and involved 3,900 volunteers between
the ages of 18
and 60 in Europe, the northern and southern US, the Xinhua news company suggested.
The trial was conducted by the
HIV Vaccine Trials Community funded by the US National Institute
Allergy and
Infectious Diseases, based at the Fred Hutchinson Cancer Study Center in Seattle.
The experimental vaccine routine
was advanced using Janssen. It relied entirely on "mosaic" immunogens,
HIV subtypes,
with the goal of inducing immune responses against a wide variety of global HIV
To get full information about Health then check link
Learn more